GlassScriptPhysician profile
Bradley C Bley
NPI 1003944406
$2,819.47
in general payments reported to CMS, 2019-2025
10 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Sports Medicine (Internal Medicine) provider received nationally (typical 2025 total: $99.49).
See the full distribution for Sports Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.66 · 2020: $2,426 · 2021: $35.73 · 2023: $83.40 · 2024: $19.18 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $2,172.46 | 2020 | |
| Pacira Therapeutics, INC. | $253.72 | 2020 | |
| Hydrocision, INC. | $143.90 | 2025 | Tenjet |
| Bioventus LLC | $73.97 | 2021-2023 | Supartz Fx Sodium Hyaluronate |
| Zimmer Biomet Holdings, INC. | $53.51 | 2023-2025 | Gel-One Cross-Linked Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $36.25 | 2023-2024 | Iovera, Zilretta |
| Nevro Corp. | $29.95 | 2019 | |
| Radius Health, INC. | $25.40 | 2019 | |
| Biocomposites INC | $17.81 | 2019 | |
| Smith+Nephew, INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Bley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.